Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
Journal of Clinical Pharmacy and Therapeutics|September 9, 2006
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxineM E E Shams, B Arneth, C Hiemke, et al.Clinical Chemistry|June 1, 1994
Monitoring tricyclic antidepressant concentrations in serum by fluorescence polarization immunoassay compared with gas chromatography and HPLCM L Rao, U Staberock, P Baumann, et al.European Archives of Psychiatry and Clinical Neuroscience|October 7, 2022
Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorderX M Hart, S Heesen, C N Schmitz, et al.Der Nervenarzt|December 18, 2012
[Antipsychotics for treatment of neuropsychiatric disorders in dementia]H-J Gertz, G Stoppe, B Müller-Oerlinghausen, et al.Animal Genetics|January 24, 2020
Genetic structure and admixture in sheep from terminal breeds in the United StatesK M Davenport, C Hiemke, S D McKay, et al.Pharmacopsychiatry|July 24, 2014
Prediction of antidepressant response to venlafaxine by a combination of early response assessment and therapeutic drug monitoringT J Stamm, D Becker, L M Sondergeld, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 6, 2005
Region specific distribution of levomepromazine in the human brainJ Kornhuber, H Weigmann, J Röhrich, et al.Pharmacopsychiatry|August 24, 2012
Non-fatal and fatal liver failure associated with valproic acidM M Schmid, R W Freudenmann, F Keller, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2007
Reboxetine and cytochrome P450--comparison with paroxetine treatment in humansU D Kuhn, M Kirsch, U Merkel, et al.Pharmacopsychiatry|September 26, 2013
Early improvement and serum concentrations of citalopram to predict antidepressant drug response of patients with major depressionE Ostad Haji, A Tadic, S Wagner, et al.Pageof 16